CD4 and influenza: We have used single or pooled 30-mer peptides for the detection of CD4+ and CD8+ T-cell responses against influenza matrix protein 1 (M1), following one round of enrichment and expansion [16], under the premise that this would also allow us to screen T-cell reactivity against a high number of pooled antigens if patient samples are limiting.